Echolase

Echolase is a startup founded with the mission to commercialize a revolutionary acoustic sensor based on the patent-pending Probe Beam Deflection Technology (PBDT), licensed from the University of Texas San Antonio Health Sciences Center. The company focuses on developing medical devices that leverage this innovative technology to provide advanced diagnostic and monitoring solutions. Echolase aims to bring laser-based acoustic sensing to both medical and industrial applications, enhancing precision and effectiveness in various fields.

Notable affiliated individuals include experts from UT Health San Antonio and seasoned advisors in the medical device industry. The company has garnered attention for its cutting-edge technology and potential to disrupt traditional diagnostic methods. Key achievements include securing the licensing rights for PBDT and advancing the development of their flagship acoustic sensor. Echolase's impact lies in its potential to significantly improve diagnostic accuracy and patient outcomes, positioning it as a promising player in the medical device market.